We recently cloned and characterized a new putative λ subunit for voltage-gated calcium channels called λ7. This stargazin-like protein exhibits 25 % homology to λ2 (Moss et al. 2002). N-type current through CaV2.2 is markedly decreased when it is transiently co-expressed with λ7 in tsA-201 cells from -60.2 ± 10.7 pA pF-1 (mean ± S.E.M., n = 44) to -15.1 ± 2.9 pA pF-1 (n = 21) at +5 mV (Student’s unpaired t test, P < 0.01) (Fig. 1A). This has also been shown in COS-7 and Xenopus oocytes (Moss et al. 2002). Furthermore, this inhibition is not due to an interference with normal trafficking of CaV subunits but to a decrease of the level of expression of CaV2.2 protein (Fig. 1B).
Over-expression of λ7 in sympathetic neurons does not affect native N-type currents, suggesting that it does not alter pre-existing functional calcium channels (Moss et al. 2002). Inhibition requires translation of λ7 as N-type currents are not significantly reduced (-49.6 ± 8.6 pA pF-1 at +5 mV, n = 28) when a stop codon is introduced two amino acids after the start codon of λ7. It was hypothesised that the last four amino acids of λ7 present in the C-terminus may be similar to the PDZ binding motif found to be important in other λ subunits. However, the removal of these four amino acids does not prevent the inhibition. Co-expression with this truncated λ7 resulted in a reduction to 21.1 ± 9.5 % (mean ± S.E.M., n = 16) of the control currents in Xenopus oocytes. We have also examined the selectivity of the inhibition by determining the effect of λ7 on other calcium channels and on a potassium channel. There was no effect of λ7 on either Ba2+ currents induced by expression of CaV3.1 (-9.8 ± 19.35 % inhibition at -10 mV, n = 17) or K+ currents induced by expression of KV3.1b (11.3 ± 11.6 % inhibition at +60 mV, n = 9) when recorded in tsA-201 cells. It appears that λ7 inhibits the expression of high voltage activated calcium channels, particularly CaV2.2, at an early stage in synthesis. Inhibition requires translation of λ7 but is not dependent on the last four amino acids, hypothesised to be similar to a PDZ binding motif. Work is currently ongoing to elucidate the mechanism of inhibition.
This work was supported by the Wellcome Trust and BBSRC.